APA引用形式

Han, J., Shi, X., Zheng, Z., Zhang, B., Shi, F., Jiang, L., & Xu, J. (2018). Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway. Drug Des Devel Ther.

シカゴスタイル引用形

Han, Jibo, Xiaowen Shi, Zhanxiong Zheng, Bin Zhang, Fengjie Shi, Liqin Jiang, , Jianjiang Xu. "Schisandrin B Protects against Angiotensin II-induced Endotheliocyte Deficits By Targeting Keap1 and Activating Nrf2 Pathway." Drug Des Devel Ther 2018.

MLA引用形式

Han, Jibo, et al. "Schisandrin B Protects against Angiotensin II-induced Endotheliocyte Deficits By Targeting Keap1 and Activating Nrf2 Pathway." Drug Des Devel Ther 2018.

警告: この引用は必ずしも正確ではありません.